Bronchodilators: implications for nursing practice
Intended for healthcare professionals
CPD Previous    

Bronchodilators: implications for nursing practice

Sue Jordan Lecturer, School of Health Science, University of Wales, Swansea
Jean White Senior Lecturer, School of Health Science, University of Wales, Swansea

Beta2-adrenoreceptor agonists are the most widely prescribed bronchodilators and are used for symptomatic control and as ‘rescue’ medication for people with asthma and other chronic conditions affecting the airways. The authors describe the clinical uses, mechanism of action and potential side effects of these agents, emphasising the nurse’s role in monitoring therapy.

Nursing Standard. 15, 27, 45-52. doi: 10.7748/ns2001.03.15.27.45.c2999

Correspondence

S.E.Jordan@swansea.ac.uk

Peer review

This article has been subject to double blind peer review

Want to read more?

RCNi-Plus
Already have access? Log in

or

3-month trial offer for £5.25/month

Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
  • Unlimited access to all 10 RCNi Journals
  • RCNi Learning featuring over 175 modules to easily earn CPD time
  • NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
  • Personalised newsletters tailored to your interests
  • A customisable dashboard with over 200 topics
Subscribe

Alternatively, you can purchase access to this article for the next seven days. Buy now


Are you a student? Our student subscription has content especially for you.
Find out more